Diagnostic Products

!! Products and documentation listed and referenced here are not available to customers within the United States.

At Epigenomics, our goal is to develop and commercialize innovative molecular diagnostic tests that address unmet needs in cancer screening, diagnosis and patient management.

Our product portfolio includes Epi proColon, a blood-based test for the early detection of colorectal cancer and Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer.

Our development pipeline also contains tests for screening, monitoring, diagnosis and prognosis assessment in colorectal, lung and prostate cancer.